Cano Health Debt to Equity Ratio 2020-2024 | CANOQ
Current and historical debt to equity ratio values for Cano Health (CANOQ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cano Health debt/equity for the three months ending March 31, 2024 was 0.00.
| Cano Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-03-31 | $2.06B | $-1.01B | -2.04 |
| 2023-12-31 | $1.55B | $-0.54B | -2.90 |
| 2023-09-30 | $1.47B | $-0.26B | -5.68 |
| 2023-06-30 | $1.47B | $0.24B | 6.24 |
| 2023-03-31 | $1.44B | $0.50B | 2.86 |
| 2022-12-31 | $1.44B | $0.49B | 2.90 |
| 2022-09-30 | $1.41B | $0.78B | 1.81 |
| 2022-06-30 | $1.30B | $0.84B | 1.55 |
| 2022-03-31 | $1.33B | $0.84B | 1.59 |
| 2021-12-31 | $1.35B | $0.80B | 1.68 |
| 2021-09-30 | $1.28B | $0.86B | 1.49 |
| 2021-06-30 | $0.77B | $0.89B | 0.87 |
| 2021-03-31 | $0.69B | $0.01B | 137.20 |
| 2020-12-31 | $0.57B | $0.05B | 11.38 |
| 2020-09-30 | $0.69B | $0.01B | 137.43 |
| 2020-06-30 | $0.69B | $0.01B | 137.50 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.001B | $3.138B |
| Cano Health Inc. is a value-based primary care provider for seniors and underserved communities. It provides health management programs including telehealth, prescription home delivery, wellness programs, transition of care and high-risk and complex care management. Cano Health Inc., formerly known as Jaws Acquisition Corp., is based in MIAMI. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $99.574B | 12.35 |
| Cencora (COR) | United States | $48.820B | 18.01 |
| DiDi Global (DIDIY) | China | $24.400B | 0.00 |
| ICON (ICLR) | Ireland | $17.737B | 15.80 |
| Natera (NTRA) | United States | $16.127B | 0.00 |
| Viatris (VTRS) | United States | $15.732B | 4.85 |
| Avantor (AVTR) | United States | $15.647B | 23.46 |
| Revvity (RVTY) | United States | $15.091B | 26.22 |
| BioMerieux (BMXMF) | France | $13.087B | 0.00 |
| Solventum (SOLV) | United States | $12.965B | 0.00 |
| CochLear (CHEOY) | Australia | $12.782B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.985B | 30.95 |
| Charles River Laboratories (CRL) | United States | $10.753B | 20.78 |
| Sonic Healthcare (SKHHY) | Australia | $8.782B | 0.00 |
| HealthEquity (HQY) | United States | $8.488B | 46.07 |
| Doximity (DOCS) | United States | $8.061B | 47.71 |
| Bausch + Lomb (BLCO) | Canada | $7.131B | 33.20 |
| Life Times (LTH) | United States | $5.102B | 33.77 |
| Sotera Health (SHC) | United States | $4.484B | 23.99 |
| Organon (OGN) | United States | $4.152B | 4.19 |
| Surgery Partners (SGRY) | United States | $3.866B | 42.83 |
| BrightSpring Health Services (BTSG) | United States | $3.294B | 70.07 |
| PACS (PACS) | United States | $3.022B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.642B | 0.00 |
| Concentras Parent (CON) | United States | $2.553B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.504B | 0.00 |
| Premier (PINC) | United States | $2.312B | 11.54 |
| GeneDx Holdings (WGS) | United States | $2.065B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.912B | 50.40 |
| Teladoc Health (TDOC) | United States | $1.637B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.555B | 10.55 |
| Progyny (PGNY) | United States | $1.492B | 26.24 |
| Pediatrix Medical (MD) | United States | $1.378B | 13.48 |
| Establishment Labs Holdings (ESTA) | $1.345B | 0.00 | |
| CareDx (CDNA) | United States | $1.281B | 0.00 |
| Agilon Health (AGL) | United States | $1.148B | 0.00 |
| Embecta (EMBC) | United States | $0.882B | 5.88 |
| InnovAge Holding (INNV) | United States | $0.821B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.687B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.506B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.479B | 0.00 |
| Enhabit (EHAB) | United States | $0.398B | 34.44 |
| DocGo (DCGO) | United States | $0.369B | 13.89 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| ModivCare (MODV) | United States | $0.256B | 13.95 |
| Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
| LifeMD (LFMD) | United States | $0.221B | 0.00 |
| Beauty Health (SKIN) | United States | $0.208B | 0.00 |
| Biodesix (BDSX) | United States | $0.193B | 0.00 |
| Nutex Health (NUTX) | United States | $0.146B | 0.00 |
| MultiPlan (MPLN) | United States | $0.142B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.142B | 0.00 |
| So-Young (SY) | China | $0.094B | 22.75 |
| Singular Genomics Systems (OMIC) | United States | $0.058B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.055B | 0.00 |
| OncoCyte (OCX) | United States | $0.048B | 0.00 |
| NeueHealth (NEUE) | United States | $0.043B | 1.15 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.021B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |